Pascal Kaeser

Pascal Kaeser, M.D.

Professor of Neurobiology, Harvard Medical School

Our goal is to understand molecular mechanisms that underlie functions and plasticity of release sites for neurotransmitters and neuromodulators. Neurons predominantly communicate through fast neurotransmission at synapses. Synaptic and neuronal activity levels are tightly controlled, and adjusted to changes in demand. Prominent cellular events that underlie these adaptations are synaptic plasticity and neuromodulation via release of non-classical transmitters. My laboratory is interested in molecular mechanisms at presynaptic neurotransmitter release sites that participate in controlling neuronal activity, and we pursue two missions. (1) It is known that synaptic vesicles containing neurotransmitters fuse exclusively at hot spots for release in presynaptic nerve terminals called active zones. Active zones are fascinating molecular machines that consist of a complex network of multi-domain proteins, orchestrating the ultrafast membrane trafficking process required for synaptic transmission. We are investigating the composition of active zones, how they operate, how they change during plasticity and learning, and how these changes tune behaviors. (2) Neuronal activity is regulated by an intriguing variety of non-classical neurotransmitters called neuromodulators. Prominent neuromodulatory substances include a multitude of neuropeptides, monoamines such as dopamine, and neurotrophins. The machinery that mediates their release, however, is poorly understood. We are dissecting the molecular apparatus that controls release of dopamine, which will reveal general mechanisms of neuromodulation. Understanding dopamine release will also provide a molecular framework to investigate aspects of neuro-psychiatric disorders. Studies in my laboratory are founded on molecular and biochemical methods to identify novel components and protein interactions at neuronal release sites. We employ techniques ranging from conditional gene targeting in mice to electrophysiological and optogenetic analyses of synaptic activity to dissect their roles.

"My laboratory is interested in molecular mechanisms at presynaptic neurotransmitter release sites that participate in controlling neuronal activity."

Publications View
Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release.
Authors: Authors: Schoch S, Mittelstaedt T, Kaeser PS, Padgett D, Feldmann N, Chevaleyre V, Castillo PE, Hammer RE, Han W, Schmitz F, Lin W, Südhof TC.
EMBO J
View full abstract on Pubmed
Role of efficient neurotransmitter release in barrel map development.
Authors: Authors: Lu HC, Butts DA, Kaeser PS, She WC, Janz R, Crair MC.
J Neurosci
View full abstract on Pubmed
RIM function in short- and long-term synaptic plasticity.
Authors: Authors: Kaeser PS, Südhof TC.
Biochem Soc Trans
View full abstract on Pubmed
Genetic evidence for a protein-kinase-A-mediated presynaptic component in NMDA-receptor-dependent forms of long-term synaptic potentiation.
Authors: Authors: Huang YY, Zakharenko SS, Schoch S, Kaeser PS, Janz R, Südhof TC, Siegelbaum SA, Kandel ER.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Phosphorylation of RIM1alpha by PKA triggers presynaptic long-term potentiation at cerebellar parallel fiber synapses.
Authors: Authors: Lonart G, Schoch S, Kaeser PS, Larkin CJ, Südhof TC, Linden DJ.
Cell
View full abstract on Pubmed
Efficient lymphoreticular prion propagation requires PrP(c) in stromal and hematopoietic cells.
Authors: Authors: Kaeser PS, Klein MA, Schwarz P, Aguzzi A.
J Virol
View full abstract on Pubmed
Complement facilitates early prion pathogenesis.
Authors: Authors: Klein MA, Kaeser PS, Schwarz P, Weyd H, Xenarios I, Zinkernagel RM, Carroll MC, Verbeek JS, Botto M, Walport MJ, Molina H, Kalinke U, Acha-Orbea H, Aguzzi A.
Nat Med
View full abstract on Pubmed
Prions: health scare and biological challenge.
Authors: Authors: Aguzzi A, Montrasio F, Kaeser PS.
Nat Rev Mol Cell Biol
View full abstract on Pubmed
Elife
Authors: Authors: Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones
2022 Nov 18; 11.
View full abstract on Pubmed